Cancer News
OncoLink Cancer News - HealthDay


Longer time-to-progression and less toxicity than chemoembolization

Monday, February 28, 2011 (Last Updated: 03/01/2011)

MONDAY, Feb. 28 (HealthDay News) -- Patients with hepatocellular carcinoma (HCC) have similar survival times whether they are treated with chemoembolization or radioembolization with Yttrium-90, but radioembolization results in less toxicity and longer time-to-progression, according to a study in the February issue of Gastroenterology.

Riad Salem, M.D., M.B.A., from Northwestern University in Chicago, and colleagues analyzed data from 245 HCC patients over a nine-year period. The effectiveness of chemoembolization, a standard of care treatment for HCC, in 122 patients was compared with radioembolization, a new transarterial approach to radiation, which was given to 123 patients. The primary outcome was overall survival, and secondary outcome measures included safety, response rate, and time-to-progression.

The researchers found that patients suffered from significantly more frequent abdominal pain and increased transaminase activity after chemoembolization. Patients treated with radioembolization had higher response rates than those treated with chemoembolization. Time-to-progression was significantly longer after radioembolization than chemoembolization, but the average survival time was not statistically different. For patients with intermediate-stage disease, survival was comparable between the two groups: 17.5 months for chemoembolization and 17.2 months for radioembolization.

"Given the results of this comparative effectiveness analysis, we believe a strong case can be made to consider Yttrium-90 at least equivalent to chemoembolization as one of the standards of care for HCC," the authors write.

Several authors disclosed financial relationships with MDS Nordion, which supported this study.

Abstract
Full Text (subscription or payment may be required)

Specialties Hematology & Oncology
Urology
Family Practice
Geriatrics
Internal Medicine
Pathology

Copyright © 2011 HealthDay. All rights reserved.


I Wish You Knew

How an oncology social worker can improve your cancer experience

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More